Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...

In just a few short months, Marathon has minted a highly quotable line: “Escape will make me God.” It’s also, according to ...

In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Meta's new hyperagent framework breaks the AI "maintenance wall," allowing systems to autonomously rewrite their own logic ...

Nvidia is looking to increase the adoption of AI by biotechnology companies, which could boost its shares, per Goldman Sachs.

Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced that Vicki Goodman, M.D., will become Recursion’s Chief Medical Officer ...

AI is making it easier to design chips and optimize software for different silicon. Some startups envision a revolution in ...

Generic formats like JSON or XML are easier to version than forms. However, they were not originally intended to be ...

We need major publicity to get across a matter of etiquette for concert and theater attendees: WAIT UNTIL THE CURTAIN CALL IS ...

New programming expands hospitality model and diversifies revenue streams amid shifting direct-to-consumer landscape. April 1 ...

Silicon Valley’s timeline for "solving" human health is dangerously optimistic, but AI is quietly breaking pharma’s biggest ...